MIF in autoimmunity and novel therapeutic approaches
Stanislava Stošić‐Grujičić(Institute for Biological Research “Siniša Stanković”), Ferdinando Nicoletti(University of Catania), Ivana Stojanović(University of Belgrade)
Cited by 86
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495